SCHEMBL31701430

SCHEMBL31701430

CC(C)(C)OC(=O)N1CCn2c(CN3CCC(c4ccc(N)cc4F)CC3)nnc2C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.41
NR1H2 P55055 1/20 0.41
TP53 P04637 2/20 0.38
LMNA P02545 2/20 0.37
ALOX5AP P20292 4/20 0.36
FEN1 P39748 4/20 0.36
DPP4 P27487 4/20 0.36
DPP8 Q6V1X1 2/20 0.36
DPP7 Q9UHL4 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP8B1 Q9UNU6 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM1A O60341 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31702217 0.86 LMNA (0.41) GPR119TP53LMNAALDH1A1CYP3A4
SCHEMBL31701387 0.82 DDB1 (0.49) GPR119LMNAALDH1A1CYP3A4CYP2D6
SCHEMBL29535803 0.79 GPR119 (0.56) GPR119NR1H2ALOX5APFEN1DPP4
SCHEMBL6395680 0.79 GPR119 (0.56) GPR119NR1H2ALOX5APFEN1DPP4
SCHEMBL20076070 0.77 GPR119 (0.55) GPR119NR1H2ALOX5APFEN1DPP4
SCHEMBL4399130 0.76 NR1H2 (0.40) NR1H2LMNAALDH1A1CYP8B1MAPT
SCHEMBL29196968 0.75 GPR119 (0.52) GPR119NR1H2ALOX5APFEN1DPP4
SCHEMBL15785400 0.75 GPR119 (0.49) GPR119NR1H2ALOX5APFEN1DPP4
SCHEMBL31333492 0.74 GPR119 (0.47) GPR119NR1H2TP53ALOX5APFEN1
SCHEMBL25121848 0.74 DRD4 (0.43) GPR119NR1H2ALOX5APFEN1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 GPR119 1280/4885NR1H2 1224/4885TP53 10/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B GPR119 1588/4885NR1H2 1188/4885TP53 9/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 GPR119 610/4885NR1H2 137/4885TP53 473/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 GPR119 1280/4885NR1H2 1224/4885TP53 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.